NIH supports Cellular Senescence Network centers to discover and validate cellular senescence signatures and biomarkers and study their roles in health and disease; clinical trials are not allowed.
NIH funding supports a Stage 2 Cellular Senescence Network center to coordinate, integrate, and share data, maintain data infrastructure, and organize consortium outreach; clinical trials are not allowed.
NIH offers five-year, milestone-driven awards to develop and validate technologies for studying senescent cell diversity and its effects on aging and disease; clinical trials are not allowed.
NIH StrokeNet seeks clinical trials and biomarker studies for stroke treatment, recovery, and prevention, offering infrastructure support for selected projects.
NIH funds centers to systematically test how genomic variants affect genome function and phenotypes, develop reproducible data pipelines, and collaborate in a consortium; clinical trials are not allowed.
This grant supports research to rigorously validate new therapeutic targets for Alzheimer's Disease-Related Dementias, aiming to accelerate treatment development through phased, milestone-driven projects.